| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects (NCT04588727) | AstraZeneca | 2020-10-15 |
| Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma (NCT04503902) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2020-10-15 |
| TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis (NCT04589260) | Theravance Biopharma | 2020-10-15 |
| GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL (NCT04601584) | AO GENERIUM | 2020-10-15 |
| Comparison of Pharmacokinetics and Safety of HS632 and Xolair® With a Single Injection (NCT04361812) | BioRay Pharmaceutical Co., Ltd. | 2020-10-15 |
| PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS (NCT04634565) | Pfizer | 2020-10-15 |
| Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder (NCT04502589) | Virginia Commonwealth University | 2020-10-15 |
| HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer (NCT03685331) | Abramson Cancer Center at Penn Medicine | 2020-10-15 |
| Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss (NCT04462198) | Contineum Therapeutics | 2020-10-15 |
| A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer (NCT04586270) | Taiho Oncology, Inc. | 2020-10-15 |
| A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340) (NCT04515953) | Nang Kuang Pharmaceutical Co., Ltd. | 2020-10-15 |
| Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors (NCT04487236) | Suzhou Zanrong Pharma Limited | 2020-10-15 |
| A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer (NCT04349280) | GlaxoSmithKline | 2020-10-15 |
| A Study of LY3522348 in Healthy Participants (NCT04559568) | Eli Lilly and Company | 2020-10-15 |
| Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 (NCT04724538) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2020-10-15 |
| A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 (NCT04587206) | Chong Kun Dang Pharmaceutical | 2020-10-15 |
| A Study to Evaluate the Metabolism and Excretion of [14C]-CC-92480 in Healthy Male Participants (NCT04560738) | Celgene | 2020-10-15 |
| A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia (NCT04510298) | Sirtsei Pharmaceuticals, Inc. | 2020-10-15 |
| Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants (NCT04567667) | Bristol-Myers Squibb | 2020-10-15 |
| A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis (NCT04737304) | BenevolentAI Bio | 2020-10-14 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB133 (Dapirolizumab Pegol) in Healthy Japanese and Caucasian Participants (NCT04571424) | Biogen | 2020-10-14 |
| IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients (NCT03227198) | SCARM Institute, Tabriz, Iran | 2020-10-14 |
| Phase 1 Study of SAR440894 vs Placebo (NCT04441905) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-10-14 |
| Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study (NCT04468425) | TWi Biotechnology, Inc. | 2020-10-14 |
| SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial (NCT04599140) | M.D. Anderson Cancer Center | 2020-10-14 |
| Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma (NCT04420975) | Jonsson Comprehensive Cancer Center | 2020-10-14 |
| [177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer. (NCT04509557) | FutureChem | 2020-10-14 |
| Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy (NCT04071236) | National Cancer Institute (NCI) | 2020-10-14 |
| Jaktinib Hydrochloride Cream For Atopic Dermatitis (NCT04435392) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2020-10-14 |
| A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT04536688) | Regulus Therapeutics Inc. | 2020-10-13 |
| Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole) (NCT04557163) | Taisho Pharmaceutical Co., Ltd. | 2020-10-13 |
| Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM (NCT04440358) | InSightec | 2020-10-13 |
| Assesment of JL1 Expression in Acute Leukemia (NCT04554381) | Assiut University | 2020-10-13 |
| 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals (NCT04250636) | Rockefeller University | 2020-10-13 |
| Phase 1 First in Human Study of ZN-d5 as a Single Agent (NCT04500587) | K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | 2020-10-13 |
| Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers (NCT04598542) | Biosplice Therapeutics, Inc. | 2020-10-13 |
| Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer (NCT04504331) | Jennifer Lee Caswell-Jin | 2020-10-13 |
| Pharmacokinetic Study of Recombinant Monoclonal Antibody Against Human Epidermal Growth Factor Receptor Injection (NCT04820439) | The Affiliated Hospital of Qingdao University | 2020-10-13 |
| A Study of JNJ-77474462 in Healthy Participants (NCT04544813) | Janssen Research & Development, LLC | 2020-10-13 |
| 68 Ga-PSMA for High Risk Prostate Cancer (NCT04614363) | The Methodist Hospital Research Institute | 2020-10-13 |
| Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies (NCT04641871) | Symphogen A/S | 2020-10-12 |
| Outpatient Treatment With CoVid-19 With Prexablu (NCT04619290) | Hospital Reg. Lic. Adolfo Lopez Mateos | 2020-10-12 |
| A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) (NCT04446650) | Bristol-Myers Squibb | 2020-10-12 |
| A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole (NCT04564040) | AstraZeneca | 2020-10-12 |
| A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies (NCT04412577) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-10-12 |
| Microbiome Effect of Omadacycline on Healthy Volunteers (NCT06030219) | University of Houston | 2020-10-12 |
| Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. (NCT03993678) | Swiss Cancer Institute | 2020-10-12 |
| Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics (NCT04585009) | GlaxoSmithKline | 2020-10-12 |
| Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy (NCT04561258) | American Gene Technologies International Inc. | 2020-10-12 |
| Remote Monitoring of Cancer Patients With Suspected Covid-19 (NCT04397705) | The Christie NHS Foundation Trust | 2020-10-12 |
| A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults (NCT04585464) | Edgewise Therapeutics, Inc. | 2020-10-12 |
| Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition (NCT05532306) | Future University in Egypt | 2020-10-11 |
| A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer (NCT04284761) | Alessa Therapeutics Inc. | 2020-10-11 |
| CD19/CD22-Dual-STAR-T for Patients With B Cell Acute Leukemia(B-ALL) (NCT04508842) | Hebei Yanda Ludaopei Hospital | 2020-10-10 |
| Effects of MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries (NCT04536233) | Chinese PLA General Hospital | 2020-10-10 |
| A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy (NCT04574401) | Intuitive Surgical | 2020-10-10 |
| Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics (NCT04678050) | Ain Shams University | 2020-10-10 |
| Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors (NCT04588324) | Chinese PLA General Hospital | 2020-10-10 |
| A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors (NCT04419532) | Daiichi Sankyo | 2020-10-09 |
| A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer (NCT04277598) | Aposcience AG | 2020-10-09 |
| A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer (NCT04572295) | Eisai Co., Ltd. | 2020-10-09 |
| Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study (NCT04536532) | Sunshine Lake Pharma Co., Ltd. | 2020-10-09 |
| A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function (NCT04056468) | Millennium Pharmaceuticals, Inc. | 2020-10-09 |
| A Study of Ralinepag in Healthy Chinese Adult Subjects (NCT04613999) | Everstar Medicines (Shanghai) Limited | 2020-10-09 |
| A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function (NCT04398745) | GlaxoSmithKline | 2020-10-09 |
| A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma (NCT04601935) | Weijun Fu | 2020-10-09 |
| A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) (NCT04565717) | Alnylam Pharmaceuticals | 2020-10-09 |
| Clinical Trials of Multivalent Opioid Vaccine Components (NCT04458545) | New York State Psychiatric Institute | 2020-10-08 |
| Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration (NCT04537884) | Unity Biotechnology, Inc. | 2020-10-08 |
| Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects (NCT04570267) | CSL Behring | 2020-10-08 |
| A Study of LY3502970 in Participants With Type 2 Diabetes (NCT04426474) | Eli Lilly and Company | 2020-10-08 |
| Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults (NCT04579250) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-10-08 |
| Targeted Therapy and Avelumab in Merkel Cell Carcinoma (NCT04261855) | Melanoma and Skin Cancer Trials Limited | 2020-10-08 |
| The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers (NCT04697654) | Taiwan Liposome Company | 2020-10-08 |
| Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD) (NCT05058105) | Qilu Pharmaceutical Co., Ltd. | 2020-10-08 |
| Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors (NCT03991741) | Gregory Daniels | 2020-10-07 |
| FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension (NCT04585100) | Future Medicine | 2020-10-07 |
| A Study to Evaluate the Relative Bioavailability of a Pediatric Granule Formulation of Ozanimod in Healthy Adult Subjects (NCT04528290) | Celgene | 2020-10-07 |
| A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 (NCT04487210) | Medigen Vaccine Biologics Corp. | 2020-10-07 |
| A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions (NCT04540900) | Krystal Biotech, Inc. | 2020-10-07 |
| A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) (NCT04758273) | Beijing Minhai Biotechnology Co., Ltd | 2020-10-07 |
| Calcium Electroporation in Patients With Cell Changes in the Esophagus (NCT04605419) | Michael Patrick Achiam | 2020-10-07 |
| INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) (NCT04398433) | Inovio Pharmaceuticals | 2020-10-07 |
| Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin (NCT04620954) | National Cancer Centre, Singapore | 2020-10-07 |
| A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors (NCT04440735) | Kahr Medical | 2020-10-07 |
| GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide (NCT04622956) | University of Sao Paulo General Hospital | 2020-10-07 |
| Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors (NCT05063318) | PharmaMar | 2020-10-07 |
| Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) (NCT04544995) | GlaxoSmithKline | 2020-10-06 |
| A Study of PTX-9908 Injection for Non-resectable HCC with TACE (NCT03812874) | TCM Biotech International Corp. | 2020-10-06 |
| A Study in Healthy Men and Women Who Are Either Between 18 - 45 Years or Between 65 - 80 Years to Test How Different Doses of BI 474121 Are Tolerated (NCT04537897) | Boehringer Ingelheim | 2020-10-06 |
| A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects (NCT04592536) | Cerevel Therapeutics, LLC | 2020-10-06 |
| Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector (NCT05264493) | Pfizer | 2020-10-06 |
| Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (NCT04604132) | Basilea Pharmaceutica | 2020-10-06 |
| A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS (NCT04477291) | Aptose Biosciences Inc. | 2020-10-06 |
| CLBS119 for Repair of COVID-19 Induced Pulmonary Damage (NCT04522817) | Lisata Therapeutics, Inc. | 2020-10-05 |
| Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR) (NCT04647903) | Vallon Pharmaceuticals, Inc. | 2020-10-05 |
| Talazoparib and Thoracic RT for ES-SCLC (NCT04170946) | University Health Network, Toronto | 2020-10-05 |
| Study to Evaluate the ECG Effects of Telaglenastat in Healthy Adult Subjects (NCT04607512) | Calithera Biosciences, Inc | 2020-10-05 |
| The BENeFiTS Trial in Beta Thalassemia Intermedia (NCT04432623) | Phoenicia BioScience | 2020-10-05 |
| A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated (NCT04540874) | Boehringer Ingelheim | 2020-10-05 |